Past events

Pharming will host a webcast to discuss the findings of a recent study published in the peer-reviewed journal Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis.

The webcast will take place on Monday, June 30, 2025, at 16:30 CEST / 10:30 EDT. To participate, please register at https://edge.media-server.com/mmc/p/q6x83at2. Questions can be submitted in advance, via email to investor@pharming.com. 

Pharming 2025 Annual General Meeting of Shareholders (AGM) will be held on Wednesday June 11, 2025, at 14:00 CEST. Click here to watch the webcast. The Notice to Convene, Explanatory Notes, Proxy and other meeting documents for the AGM can be found on the Company’s website under Investors/Shareholder Meetings.

Jefferies Global Healthcare Conference. New York, US, June 4-5, 2025. Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Thursday, June 5 at 2:00 pm EDT/20:00 CEST (view webcast)

Michael Levitan, VP Investor Relations and Corporate Communications will present on Tuesday, May 20 at 09:00 EDT/15:00 CET. Download the presentation below:

Pharming reported 1Q 2025 financial results on May 8, 2025 at 07:00 CET. You can find this and other results on our Financial Documents page. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2025. Register for the 1Q 2025 conference call and webcast below:

Pharming announced the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the Clinical Immunology Society (CIS), taking place May 1-4, 2025 in Philadelphia, PA. Read more about the presentation in the press release below.

• 24th Annual Needham Virtual Healthcare Conference, April 7-10, 2025
  Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Tuesday, April 8 at 10:15 am ET/16:15CET. View webcast and download the presentation slides below.

The Annual Report 2024 will be released on April 3, 2025.

• Van Lanschot Kempen Life Sciences Conference 2025, Amsterdam, NL, April 2-3, 2025

• 37th Annual ROTH Conference, Dana Point, CA, USA, March 16-18, 2025
  Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT/21:30 CET. 

Pharming reported 4Q/FY 2024 financial results on March 13, 2025 at 07:00 CET. Download the press release, presentation & transcript (view webcast) below. You can find this and other results on our Financial Documents page.

Pharming will hold an Extraordinary General Meeting of Shareholders (EGM) on March 4, 2025, at 14:00 CET.
Click here to watch the live webcast.

• Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025
  Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET/14:40 CET. (view live webcast)

DeGroof Petercam Virtual Healthcare Conference 2025

Pharming announced public cash offer to the shareholders of Abliva AB on Sunday December 15, 2024. Pharming will host a conference call on Monday, December 16, 2024, at 14:00 CET (8:00 am EST) (view live webcast)

Jefferies London Healthcare Conference 2025, London, U.K., November 19-21
Sijmen de Vries, Chief Executive Officer will present on Wednesday, November 20 at 08:00 GMT/09:00 CET (view live webcast).

Pharming reported 3Q 2024 financial results on October 24, 2023 at 07:00 CET. Download the press release, presentation & transcript (view webcast) below. You can find this and other results on our Financial Documents page.

Sijmen de Vries, Chief Executive Officer, will present on Monday, September 9 at 10:30 AM ET/16:30 CET. Click here to watch the live webcast. Download the presentation slides below.

Sijmen de Vries, Chief Executive Officer, will participate in a fireside chat question and answer session on Friday, September 6 at 08:45 AM ET/14:45 CET. Click here to watch the webcast. Download the presentation slides below

Pharming reported 2Q/1H 2024 financial results on August 1, 2024 at 07:00 CET. Download the press release, presentation & transcript (view webcast) below. You can find this and other results on our Financial Documents page.

Oppenheimer 2024 Montauk Life Sciences Summit, Montauk, NY, USA, June 26-28, 2024

Anurag Relan, Chief Medical Officer, will participate in the panel “Taking the Inflammation out of I&I - Novel Approaches for Inflammatory Disorders” on Monday, June 24 at 13:30EDT/19:30CEST.

Sijmen de Vries, Chief Executive Officer, will present on Wednesday, June 5 at 10:30EDT/16:30CEST. Click here to rewatch the webcast. Download the presentation slides and transcript below.

On May 21, 2024 at 14:30 CEST Pharming will hold an Annual General Meeting (AGM). Click here to watch the live webcast.

Michael Levitan, VP Investor Relations and Corporate Communications will present on Monday, May 20 at 09:30 EDT/15:30 CET.

Pharming reported 1Q 2024 financial results on May 8, 2024 at 07:00 CET. Download the press release, presentation & transcript (view webcast) below. You can find this and other results on our Financial Documents page.

Van Lanschot Kempen Life Sciences Conference 2024, Amsterdam, NL, April 16-17, 2024

Sijmen de Vries, Chief Executive Officer, presented on Monday, April 8 at 8:45ET/14:45CEST. Click here to rewatch the webcast and download the presentation slides and transcript below.

 The Annual Report 2023 will be released on April 4, 2024.

Pharming to report 4Q/FY 2023 financial results on March 14, 2024 at 07:00 CET. You can find other results on our Financial Documents page.

Pharming’s management will attend the UBS European Healthcare Conference in London on February 28.

Six leading experts will take attendees through an interactive deep dive into a rare patient case of APDS and will discuss clinical presentation, diagnosis, and management with a targeted treatment at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. Please see below for additional details:  

• Date:  Sunday, February 25, 2024 
• Time: 6:30-8:30pm ET  
• Location:  Meeting Level 2, Marquis 5, Marriott Marquis, Washington, DC

An oral abstract presentation on Clinical and Genetic Findings of Individuals Tested via the navigateAPDS Sponsored Genetic Testing Program took place at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC on Saturday, February 24, 2024 at 2:25-2:35 pm ET. 

More information on the abstract can be found here: Abstract listing.

Sijmen de Vries, Chief Executive Officer, presented on Tuesday, February 13 at 11:20 ET/17:20 CET. Click here to rewatch the webcast and download the presentation slides and transcript below.

Jefferies London Healthcare Conference 2023, London, U.K., November 14-16
Sijmen de Vries, Chief Executive Officer will present on Wednesday, November 15 at 08:30 GMT/09:30 CET. Download the presentation slides below.

Pharming announced poster presentations by the Company or its collaborators at American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, Anaheim, California, U.S, November 9 – 13, 2023. More information, including dates and time, can be found below.

Pharming announced poster presentations by the Company or its collaborators at International Primary Immunodeficiencies Congress (IPIC) Rotterdam, The Netherlands, November 8 - 10, 2023. More detailed information, including dates and time can be found below.

Pharming Group reported third quarter 2023 financial results on October 26, 2023 at 07:00 CET. You can find this and other results on our Financial Documents page.
Pharming hosted a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023 (rewatch webcast).
Download the press release, presentation & transcript below.

2023 Cantor Global Healthcare Conference takes place in New York on September 26-28. Michael Levitan, VP Investor Relations and Corporate Communications, will present on Thursday, September 28 at 10:20 ET/16:20 CET.

Pharming Group N.V. will hold an Extraordinary General Meeting of Shareholders (EGM) on Monday, September 25, 2023 at 14:00 CEST. (rewatch webcast)

The Notice to Convene, Explanatory Notes, Voting information, meeting documents and Form of Proxy can be found under Investors/Shareholder Meetings.

H.C. Wainwright 25th Annual Global Investment Conference takes place in New York on September 11-13. Sijmen de Vries, Chief Executive Officer, will present on Wednesday, September 13 at 08:30 ET/14:30 CET. Click here to watch the webcast.

2023 Wells Fargo Healthcare Conference takes place in Boston on September 6-8. Sijmen de Vries, Chief Executive Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Thursday, September 7 at 16:30 ET/22:30 CET. Click here to watch the webcast.

Pharming Group reported second quarter and first half 2023 financial results on August 3, 2023 at 07:00 CET. You can find this and other results on our Financial Documents page.
Pharming hosted a presentation for analysts and investors at 13:30 CEST/07:30 EDT on August 3, 2023 (rewatch webcast).
Click below for more information and to download the presentation slides and transcript.

Pharming’s management will attend the IEX Beleggersdag, Bussum, the Netherlands, June 30. Pharming’s CEO, Sijmen de Vries, will present on Friday, June 30 at 11:30 CEST / 05:30 EST. Download the presentation below.

Pharming’s management will attend the Stifel European Healthcare Summit, Bordeaux, France, June 28 - 30. Download the presentation below.

Pharming’s management attended the Jefferies Healthcare Conference, New York, U.S., June 7 - 9. Pharming’s CEO, Sijmen de Vries, presented on Thursday, June 8 at 10:30 EST / 16:30 CEST. Click here to rewatch the webcast and download the presentation below.

On May 17, 2023 at 14:00 CEST Pharming will hold an Annual General Meeting (AGM). Click here to rewatch the webcast and download the presentation below. 

Pharming reported first quarter 2023 financial results on May 11, 2023 at 07:00 CET. You can find this and other results on our Financial Documents page.

The Company hosted a presentation for analysts and investors at 13:30 CET/07:30 ET on May 11, 2023 (rewatch webcast). Click below for more information and to download the presentation slides and the transcript.

Pharming’s Chief Executive Officer, Sijmen de Vries will attend the H.C. Wainwright BioConnect Investor Conference 2023 on May 2, 2023 in New York and will take part in a fireside chat at 11:00 ET/17:00 CEST. Download the presentation slides below.

Pharming’s Chief Executive Officer, Sijmen de Vries and Chief Financial Officer, Jeroen Wakkerman will attend the Van Lanschot Kempen Life Sciences Conference on April 25 and 26, 2023 in Amsterdam, the Netherlands.

Pharming’s management will be available for one-to-one investor meetings during the conference. Download the presentation slides below.

Pharming’s management will attend the 22nd Annual Needham Virtual Healthcare Conference April 17 - 20, 2023. Pharming’s CEO, Sijmen de Vries, presented on April 20 at 08:00 ET /14:00 CEST. Click here to rewatch the webcast and download the presentation slides below.

The Annual Report 2022 will be released on April 5, 2023.

Pharming’s Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will attend the Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days, April 3 - 4, 2023 in New York. Pharming’s CEO and CCO will take part in a fireside chat on April 3 at 15:20 ET /21:20 CEST. Click here to replay the live webcast and download the presentation slides and transcript below.

Pharming announced US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS on March 24, 2023. Pharming held a conference call for investors and analysts on March 27 at 14:00 CEST/08:00 EST. (rewatch webcast). Download press release, the presentation slides and transcript of the call below, 

The full year 2022 financial results were released on March 16, 2023 at 07:00 CET. You can find this and other results on our Financial Documents page.

The Company will host a presentation for analysts and investors at 13:30 CET/08:30 ET on March 16, 2023 (webcast). More information and dial in details can be found below.

The Degroof Petercam Healthcare Conference will take place on January 25, 2023.

The J.P. Morgan 41st Annual Healthcare Conference 2023 took place January 9-12, 2023 in San Francisco.

The Solebury Strategic Communications 1x1 Management Access Event took place January 9-11, 2023 in San Francisco.

View Corporate Overview Presentation slides

The Jefferies London Healthcare Conference took place November 15-17, 2022 in London. Our Chief Executive Officer, Sijmen de Vries, presented on Tuesday, November 15, 2022 at 09:45 GMT / 10:45 CET.

The Stifel Healthcare Conference 2022 took place in New York on November 15-16, 2022. Our Chief Financial Officer, Jeroen Wakkerman, presented on Tuesday, November 15 at 08:00 ET / 14:00 CET.

The Credit Suisse 31st Annual Healthcare Conference 2022 took place in Rancho Palos Verdes, California, November 7-10, 2022. Pharming’s CEO, Sijmen de Vries and CMO, Anurag Relan, were available for one-to-one investor and corporate meetings during the conference.

The Q3 results were released on October 27, 2022, at 07:00 CET. You can find this and other results on our Financial Documents page.

The Company held a presentation for analysts on October 27, 2022 at 13:30 CET/07:30 ET. To launch the audio webcast recording of the call please click on this link. 
Presentation slides and a transcript of the call can be downloaded below.

The H.C. Wainwright 24th Annual Global Investment Conference takes place on September 12-14, 2022. 
Our CEO, Sijmen de Vries held a presentation on September 13, 2022 at 09:30 ET/15:30 CET.

H1 2022 results were released on August 4, 2022, at 07:00 CET. You can find this and other results on our Financial Documents page.

The Company held an analyst conference call on August 4, 2022 at 13.30 CET/07.30 EST. To launch the audio webcast recording of the call please click on this link. 

Presentation slides and a transcript of the call can be downloaded below.

The Jefferies Healthcare Conference 2022, has taken place from 8-10 June 2022. Our Chief Executive Officer, Sijmen de Vries, held a presentation on 9 June 2022 that can be found by clicking on this link.

On May 18, 2022 Pharming held an AGM. You can find more information on our shareholder meetings page.

Rewatch the AGM webinar

The 16th of May is the annual HAE day to raise HAE awareness across the world.

The Q1 results were released on May 12, 2022 at 07:00 CET. You can find this and other results on our Financial Documents page.

The Annual Report was released on the 6th of April 2022. You can find this and other financial documents linked below.

Sign up now! Pharming Webinar Full Year Financial Results 2021

Pharming’s CEO Sijmen de Vries and CFO Jeroen Wakkerman look back at 2021 and the recently published full year financial results.

On the 24th of March 2022 at 19:00 CET Pharming Group will hold a webinar for our retail shareholders in which CEO Sijmen de Vries and CFO Jeroen Wakkerman will review the full year financial results of 2021. This webinar will include a business update, insight into market developments, pipeline progress and a financial review. It will conclude with a Q&A session.

To submit questions to the Q&A session, please send us an email at investor@pharming.com until 17:00CET on the 22nd of March 2022 with the subject ‘Pharming Webinar’, to keep the webinar as organized as possible we will not be answering questions during the webinar. This webinar will be broadcast in English.

The full year results will be released at 07:00 CET on the 17th of March 2022.

Following the announcement of the positive leniolisib results Pharming will hold an analyst conference call on Thursday 3 February, at 14:00CET/08:00ET. Watch the webcast here

Dial-in details for the call can be found on page 5 of the press release.

This year the Stifel Healthcare Conference took place virtually. Read more about Stifel.

This year the Jefferies London Healthcare Conference took place virtually. 

The Q3 results were released at 07:00 CET. You can find the results on our Financial Documents page.

This year the Morgan Stanley Global Healthcare Conference took place virtually. Read more about the Morgan Stanley Global Healthcare Conference.

The half year results were released at 07:00 CET. You can find the results on our Financial Documents page.

Pharming’s CEO Sijmen de Vries and CFO Jeroen Wakkerman look back at the first half of 2021 and the recently published full year financial results.

Replay the webinar

This year the EAACI took place in Madrid and Krakow. Read more about EAACI.

This year the JP Morgan European Healthcare Conference took place virtually. 

This year the Jefferies Healthcare Conference took place virtually. Read more about the Jefferies Healthcare Conference.

On the 19th of May Pharming held an AGM. You can find more information on our shareholder meetings page.

Rewatch the AGM webinar

This year BIO€QUITY EUROPE took place virtually. Read more about BIO€QUITY EUROPE.

The 16th of May is the annual HAE day to raise HAE awareness across the world.

The Q1 results were released at 07:00 CET. You can find the results on our Financial Documents page.

The Annual Report was released on the 6th of April 2021.

This year the JP Morgan, Pan European Virtual Small/Mid Cap Conference took place virtually. 

This year the Oppenheimer & Co Healthcare Conference takes place virtually. Read more about the Oppenheimer & Co Healthcare Conference.

This year the BioCapital Europe organized by LSP took place virtually. Read more about BioCapital Europe organized by LSP.

Pharming released the full year results at 07:00 CET. You can find the results on our Financial Documents page.

On the 4th of March 20201 Pharming Group held a webinar in which CEO Sijmen de Vries and CFO Jeroen Wakkerman reviewed the full year financial results of 2020. This webinar included a business update, insight into market developments, pipeline progress and a financial review.

Replay the webinar

This year the JP Morgan Healthcare Conference took place virtually. Read more about the JP Morgan Healthcare Conference.

This year the Solebury Trout Management Access Event took place virtually. Read more about the Solebury Trout Management Access Event.

This year our Extraordinary General Meeting took place in the Johan Cruijff arena. You can find more information on our shareholder meetings page.

This year the Jefferies Healthcare Conference took place virtually.

This year the Stifel Healthcare Conference took place virtually.

You can find the Pharming Q3 Results on our Financial Documents page.

This year the BioCapital Europe organized by LSP took place virtually.

This year the Morgan Stanley Conference took place virtually.

This year the H.C. Wainwright Global Life Sciences Conference took place virtually.

You can find the Pharming Half Year Results at our Financial Documents page.

This year the WISC Conference took place virtually. 

This year the Portzamparc Conference took place virtually. 

This year the EAACI took place virtually. 

This year our Annual General Meeting took place in our headquarters in Leiden. You can find more information on our shareholder meetings page.

The 16th of May is the annual HAE day to raise HAE awareness across the world.

This year the HAEi Global Conference took place virtually. 

You can find the Pharming Q1 Results on our Financial Documents page.

You can find the Pharming Annual Report 2019 on our Financial Documents page.

This year the J.P. Morgan Small/Mid Cap Conference took place in London. 

You can find the Pharming Full Year Results on our Financial Documents page.

This year the JP Morgan Healthcare Conference took place in San Francisco. 

The annual Investor Tour took place in multiple cities in The Netherlands. On the 9th of January 2020 Pharming organized the Investor Tour in Zwolle.